Loading clinical trials...
Loading clinical trials...
A multi-center, prospective, registry study to analyze the clinical characteristics and prognosis of different molecular subtypes of peripheral T-cell lymphoma.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Ruijin Hospital
Collaborators
NCT07470996 · Peripheral T Cell Lymphoma
NCT07389616 · Peripheral T Cell Lymphoma
NCT07356245 · T-cell Lymphoma, Graft Versus Host Disease, and more
NCT07353840 · Peripheral T Cell Lymphoma
NCT07253129 · Peripheral T Cell Lymphoma
Peking University People's Hospital
Beijing
Henan Cancer Hospital
Henan
Affiliated Drum Tower Hospital, Medical School of Nanjing University
Nanjing
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions